- Room N16, ITTC Building, Plymouth Science Park, Davy Road
- wendy.ingram@plymouth.ac.uk
Profiles
Dr Wendy Ingram
Trial Manager
Peninsula Medical School (Faculty of Health)
Role
Clinical Trials Manager for Peninsula Clinical Trials Unit
Qualifications
PhD Pharmacokinetic and pharmacodynamic modelling of subcutaneous apomorphine in the treatment of idiopathic Parkinson's disease
BSC (Hons) Biomedical Technology
Professional membership
UK Trial Managers Network
Research interests
Randomised controlled trials:
ACCEPT: Ability and quality of life for Children with CErebral Palsy Trial
CAMS: Cannabinoids in multiple sclerosis
e-coachER: Web support for exercise referrals
DIAT: Efficacy of a patient-orientated agenda for use in the diabetes clinical consultation
NoPac: Novel use of Tranexamic Acid to reduce the need for nasal packing in epistaxis
TARS: Trial of physical activity for smoking reduction
The TACIT Trial: Tai Chi for people with dementia
REVERT: Evaluation of modified Valsalva effectiveness in re-entrant tachycardias
Other studies:
MCL Biobank: Biobank database for indolent and aggressive forms of Mantle Cell LymphomaThe SWIMS Project: Prospective longitudinal study of multiple sclerosis in South West England
Key publications are highlighted
Journals
Articles
2019
'Randomised Controlled Trial Of The Effect Of Tai Chi On Postural Balance Of People With Dementia'
Clinical Interventions in Aging
Volume 14,
2017-2029
, DOI
PEARL
2018
'A randomised controlled trial comparing the effectiveness of tai chi alongside usual care with usual care alone on the postural balance of community-dwelling people with dementia: protocol for the TACIT trial (TAi ChI for people with demenTia)'
BMC Geriatrics
18,
(1)
263-263
, DOI
PEARL
2018
'Multicentred randomised controlled trial of an augmented exercise referral scheme using web-based behavioural support in individuals with metabolic, musculoskeletal and mental health conditions: protocol for the e-coachER trial'
BMJ Open
8,
(9)
, DOI
PEARL
2017
'A preconsultation web-based tool to generate an agenda for discussion in diabetes outpatient clinics to improve patient outcomes (DIAT): a feasibility study'
BMJ Open
7,
(3)
e013519-e013519
, DOI
PEARL
2013
'A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT)'
BMJ Open
3,
(7)
e003396-e003396
, DOI
PEARL
2013
'Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures'
Mult Scler
19,
(12)
1632-1639
, DOI
2011
'Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis'
Nature
476,
(7359)
214-219
, DOI
PEARL
2010
'Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort'
BMC Neurol
10,
, DOI
PEARL
2006
'Improved assay for R(-)-apomorphine with application to clinical pharmacokinetic studies in Parkinson's disease'
J Chromatogr B Analyt Technol Biomed Life Sci
831,
(1-2)
1-7
, DOI
2006
'Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88)'
Journal of Neurology Neurosurgery and Psychiatry
77,
(1)
2006
'Meaningless statistics and the illusion of fatigue'
Journal of Neurology Neurosurgery and Psychiatry
77,
(1)
2005
'Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up'
J Neurol Neurosurg Psychiatry
76,
(12)
1664-1669
, DOI
2005
'Getting the measure of spasticity in Multiple Sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS - 89)'
Brain
129,
(1)
224-234
, DOI
2005
'Confounding the confused: is measuring the frequency and severity of cognitive impairment really necessary?'
Multiple Sclerosis
11,
S68-S68
2005
'Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88)'
Journal of the Neurological Sciences
238,
S229-S229
2004
'Cannabinoids in multiple sclerosis (CAMS) study, follow-up data suggesting an effect on disease progression'
Journal of Neurology
251,
44-44
1999
'Dose optimisation for amorphine in Parkinson's disease: Pharmacokinetic-pharmacodynamic (PK-PD) studies'
Journal of Pharmacy and Pharmacology
51,
(SUPPL.)
Conference Papers
2006
'Does the GHQ-30 leave room for change?'
1-/-0/1900
1-/-0/1900
134-134
2006
'Introducing the south west impact of multiple sclerosis (SWIMS) project: A population-based natural history project to acquire patient-orientated information about the impact of multiple sclerosis'
1-/-0/1900
1-/-0/1900
131-131
Posters
Rory McCulloch, Alexandra Smith, Brian Wainman, Wendy Ingram, Amelia Lewis, Matthew Hawkins, Nicola Crosbie, Andrew Pettitt, Simon Rule. 2019. 40% of Females with Mantle Cell Lymphoma Are Managed with Initial Observation: Results from the MCL Biobank Observational Study Blood (2019) 134 (Supplement_1): 2821. DOI: https://doi.org/10.1182/blood-2019-128340
Wendy Ingram, Lisa Price, Brian Wainman, Rod Taylor, Adrian Taylor. P-83 Objective measurement of participants’ physical activity: use of accelerometry in e-coachER - a randomised controlled trial of web-based support in exercise referral schemes https://ictmc2019.com/abstracts/
Helen Hancocks, Jennie King, Alex Gude, Shaun Treweek, Wendy Ingram, Tom Thompson, Adrian Taylor, Siobhan Creanor. P-143 The effect of the method of invitation on recruitment of participants from GP practices to a trial of a smoking reduction intervention: a study within a trial https://ictmc2019.com/abstracts/